Grant: Collaborative Research and Development Grants
Université de Montréal
$60,000.00
Imaging mass spectrometry of steroids
FY 2014-15
Summary
Imaging Mass Spectrometry (IMS) is a technology that provides information on the spatial distribution of biomolecules in thin tissue sections in direct correlation with the underlying histology. The potential of IMS analysis, in which the spatial distribution of biomolecules can be mapped throughout a tissue section, is particularly exciting for the study of neurodegenerative diseases. We propose herein to develop and optimize new methodologies for the selective on-tissue derivatization of steroids to facilitate their detection and quantitation by IMS. We will also develop micro-extraction, purification and quantitation methods to efficiently measure endogenous steroids in tissues by LC- (tandem) MS. Finally, with these MS assays, weenvision identifying and quantifying several active steroids in cynomolgus monkey brain. The investigation of distributions and quantities of active steroids in control and chemically altered brain tissues will give us better insights into some of the mechanisms leading to Alzheimer's disease. Specifically, this project will shed some light on the contribution of peripheral DHEA (which may have a pharmaceutical value against Alzheimer's disease) in the production of neurosteroids. Overall, this R&D project should provide novel and much needed methods to the scientific community to accurately measure tissue levels of steroids by IMS and LC- (tandem) MS with applications in clinical research to monitor and understand the role of steroid hormones in numerous diseases, including neurodegenerative diseases and cancer. Such advances will facilitate the development of novel preventive therapies.
Program
Collaborative Research and Development Grants
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
461818-2013
Name nom
Chaurand, Pierre
Department département
Chimie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2013
Award amount
60000
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3500
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Analytical chemistry
Research subject fr
Chimie analytique
Partie
1
Nb partie
2
Application title
Imaging mass spectrometry of steroids
Keyword
NSERC
Application summary
Imaging Mass Spectrometry (IMS) is a technology that provides information on the spatial distribution of biomolecules in thin tissue sections in direct correlation with the underlying histology. The potential of IMS analysis, in which the spatial distribution of biomolecules can be mapped throughout a tissue section, is particularly exciting for the study of neurodegenerative diseases. We propose herein to develop and optimize new methodologies for the selective on-tissue derivatization of steroids to facilitate their detection and quantitation by IMS. We will also develop micro-extraction, purification and quantitation methods to efficiently measure endogenous steroids in tissues by LC- (tandem) MS. Finally, with these MS assays, weenvision identifying and quantifying several active steroids in cynomolgus monkey brain. The investigation of distributions and quantities of active steroids in control and chemically altered brain tissues will give us better insights into some of the mechanisms leading to Alzheimer's disease. Specifically, this project will shed some light on the contribution of peripheral DHEA (which may have a pharmaceutical value against Alzheimer's disease) in the production of neurosteroids. Overall, this R&D project should provide novel and much needed methods to the scientific community to accurately measure tissue levels of steroids by IMS and LC- (tandem) MS with applications in clinical research to monitor and understand the role of steroid hormones in numerous diseases, including neurodegenerative diseases and cancer. Such advances will facilitate the development of novel preventive therapies.